Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Laryngoscope ; 131(7): E2363-E2370, 2021 07.
Article in English | MEDLINE | ID: mdl-33382113

ABSTRACT

OBJECTIVES/HYPOTHESIS: To determine the rate and predictors of receiving multiple tympanostomy tube (TT) placements in children. STUDY DESIGN: Systematic review and meta-analysis. METHODS: PubMed, EMBASE, and Cochrane Library databases were searched for studies reporting the risk factors for receiving repeat TT (r-TT) placements in children with chronic otitis media with effusion or recurrent acute otitis media. These articles were systematically reviewed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) recommendations. Data were pooled using a random-effects model. RESULTS: Twenty-one studies involving a total of 290,897 children were included. Among all patients, 24.1% (95% confidence interval (CI), 18.2%-29.9%) underwent ≥2 TT placements and 7.5% (95% CI, 5.7%-9.4%) underwent ≥3 TT placements. Craniofacial disease (odds ratio (OR) 5.13, 95% CI, 1.57-16.74) was the strongest predictor of r-TT. Younger age at initial TT placement and shorter TT retention time were also significantly associated with r-TT. Receipt of primary adenoidectomy with initial TT placement was associated with decreased odds of r-TT (OR, 0.46; 95% CI, 0.39-0.55). Long-term tubes also significantly reduced the odds of r-TT (OR, 0.27; 95% CI, 0.17-0.44). CONCLUSIONS: About 1 in 4 children receiving TT will receive at least one repeat set of TT and about 1 in 14 will receive multiple repeat sets. Concurrent adenoidectomy and long-term tubes reduced the incidence of r-TT. Younger patients and those with earlier extrusion of the initial set are at increased risk for repeat surgery. The identification of these risk factors may improve parental counseling and identify patients who might benefit from closer follow-up. LEVEL OF EVIDENCE: NA Laryngoscope, 131:E2363-E2370, 2021.


Subject(s)
Adenoidectomy/statistics & numerical data , Device Removal/statistics & numerical data , Middle Ear Ventilation/statistics & numerical data , Otitis Media/surgery , Reoperation/statistics & numerical data , Aftercare , Child , Chronic Disease/therapy , Humans , Middle Ear Ventilation/instrumentation , Protective Factors , Recurrence , Risk Factors , Time Factors , Treatment Outcome
3.
Laryngoscope ; 131(5): E1714-E1721, 2021 05.
Article in English | MEDLINE | ID: mdl-33017065

ABSTRACT

OBJECTIVES/HYPOTHESIS: While virtual reality (VR) has been used as analgesia and anxiolysis for invasive procedures, no literature exists on the use of VR in the pediatric otolaryngology setting. The purpose of this study was to determine the efficacy of VR in reducing pain and anxiety for pediatric otolaryngology patients. STUDY DESIGN: Randomized controlled trial. METHODS: A total of 53 patients aged 7-17 undergoing in-office nasal endoscopies were included. Patients were randomized to receive VR or standard of care. Procedural pain, anxiety, and satisfaction scores were recorded from patients and caregivers. The physician filled out a childhood emotional manifestation scale (CEMS). RESULTS: Patients in VR group reported a significant decrease in pain (0.80 ± 1.06 vs. 2.26 ± 2.38, P = .018) and anxiety (9.50 ± 12.48 vs. 38.48 ± 29.83, P = .0002) and increase in procedural satisfaction (6.40 ± 0.77 vs. 4.74 ± 1.74, P = .0002) compared to patients in control group. CEMS scores were significantly reduced in VR group (5.15 ± 0.46 vs. 9.64 ± 5.66, P = .0001) and caregiver anxiety levels were significantly reduced in VR group (11.50 ± 17.67 vs. 27.39 ± 30.48, P = .041) compared to control group. There were no reported side effects. Procedural time did not significantly differ between groups. CONCLUSIONS: For pediatric otolaryngology patients undergoing in-office nasal endoscopies, VR is a safe and effective form of distraction analgesia and anxiolysis, significantly reducing pain and increasing procedural satisfaction for patients. In addition, VR significantly reduces anxiety for both patients and caregivers without disrupting procedural efficiency and workflow. LEVEL OF EVIDENCE: 2. Laryngoscope, 131:E1714-E1721, 2021.


Subject(s)
Analgesia/methods , Anxiety/therapy , Endoscopy/adverse effects , Nasal Surgical Procedures/adverse effects , Pain, Procedural/therapy , Virtual Reality , Adolescent , Anxiety/diagnosis , Anxiety/psychology , Caregivers/psychology , Child , Endoscopy/instrumentation , Endoscopy/psychology , Female , Humans , Male , Nasal Surgical Procedures/instrumentation , Nasal Surgical Procedures/psychology , Pain Measurement , Pain, Procedural/diagnosis , Pain, Procedural/etiology , Pain, Procedural/psychology , Patient Satisfaction , Treatment Outcome , Video Games
4.
Otolaryngol Clin North Am ; 52(6): 1037-1048, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31521368

ABSTRACT

Airway endoscopy (rigid and flexible bronchoscopy) is an important procedure that allows for visualization of the trachea and bronchi as well as treatment of a variety of airway disorders for diagnostic and therapeutic interventions. Excellent communication between the anesthesiologist and the endoscopist is required to ensure that adequate oxygenation and ventilation is maintained via the shared airway. Various anesthetic and airway management techniques can be used for airway management in pediatric foreign-body aspiration. This article highlights indications, techniques, and complications encountered during pediatric bronchoscopy, with particular focus on anesthetic management of the pediatric airway.


Subject(s)
Airway Management/methods , Anesthesia/methods , Bronchoscopy , Child , Foreign Bodies/diagnosis , Foreign Bodies/therapy , Humans , Interdisciplinary Communication , Pediatrics , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/therapy
5.
J Rheumatol ; 33(5): 1004-13, 2006 May.
Article in English | MEDLINE | ID: mdl-16583463

ABSTRACT

OBJECTIVE: To describe the differences between patients with systemic sclerosis (SSc) having childhood versus adult onset evaluated at a single medical center. METHODS: Patients were divided into those with childhood onset (first SSc symptom or finding before age 16 yrs) and those with early adult and late adult onset. The 3 groups were compared with respect to disease classification, clinical, laboratory and serologic data, and survival. RESULTS: One hundred eleven childhood onset SSc cases seen between 1960 and 2003 were compared with 2559 adult onset SSc cases (1087 with onset age 16-40 and 1472 with onset after age 40 yrs) first evaluated between 1972 and 2001. Age distribution at onset was unimodal, suggesting that childhood disease is part of the spectrum of adult onset SSc. A significantly greater proportion of childhood onset patients had overlap syndromes, most frequently with polymyositis-dermatomyositis (PM-DM), and skeletal muscle involvement. Children with diffuse cutaneous (dc) SSc had significantly lower maximum mean total skin thickness scores than adult patients with dcSSc. Renal involvement was uncommon in childhood onset cases, and the frequency increased with age of onset. Serum anti-PM-Scl and anti-U1RNP antibodies were detected significantly more frequently in childhood than in adult onset cases. In contrast, anti-RNA polymerase III and anticentromere antibodies were found significantly more frequently in adults. Survival was significantly better among childhood than all adult onset cases combined, but similar to survival in young adult onset SSc cases. Scleroderma heart disease was a frequent cause of death among children with SSc. CONCLUSION: Patients with juvenile onset SSc more frequently have an overlap syndrome with PM-DM, higher frequency of skeletal muscle involvement, serum anti-PM-Scl and anti-U1RNP antibody, fatal cardiac disease, and improved survival compared with adult onset SSc cases.


Subject(s)
Outcome Assessment, Health Care , Scleroderma, Systemic/classification , Scleroderma, Systemic/epidemiology , Adult , Age of Onset , Autoantibodies/blood , Autoantigens/blood , Autoantigens/immunology , DNA Topoisomerases, Type I/immunology , Dermatomyositis/physiopathology , Exoribonucleases , Exosome Multienzyme Ribonuclease Complex , Female , Heart Diseases/physiopathology , Humans , Male , Middle Aged , Muscle, Skeletal/physiopathology , Prognosis , RNA Polymerase III/immunology , Scleroderma, Systemic/mortality , Scleroderma, Systemic/physiopathology , Severity of Illness Index , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...